| EPC223 | Population-level trends in HIV pre exposure prophylaxis (PrEP) knowledge, interest and use among indigenous two-spirit and gay, bisexual, queer, and trans men and non-binary people in Canada, 2015-2020 | E-poster | Scale up of PrEP |
| EPC224 | Acceptability of long-acting injectable prep administration by health workers in Kampala, Uganda; a cross-sectional study | E-poster | Scale up of PrEP |
| EPC225 | Trends in HIV post-exposure prophylaxis following sexual exposure (PEPSE) in Brazil (2011-2019) | E-poster | Scale up of PEP |
| EPC226 | Long-term follow-up of individuals using HIV post-exposure prophylaxis-in-pocket ('PIP') for high risk, low frequency exposures | E-poster | Scale up of PEP |
| EPC227 | Awareness and openness to using PrEP among a nationally representative sample of South African Adults | E-poster | Scale up of PEP |
| EPC228 | Evaluation of the use of post-exposure prophylaxis for HIV in transgender women a few months before the implementation of pre-exposure prophylaxis in Goiânia, Brazil | E-poster | Scale up of PEP |
| EPC229 | Seasonality and male circumcision: an analysis of quarterly PEPFAR-supported voluntary medical male circumcisions for HIV prevention, 2016 ' 2019 | E-poster | Scale up of medical male circumcision |
| EPC230 | Timing for maximum anesthetic effect of topical cream during early infant male circumcision (EIMC) in Rakai, Uganda | E-poster | Scale up of medical male circumcision |
| EPC231 | Strengthening safety through surveillance: notifiable adverse events in the U.S. President's Emergency Plan for AIDS Relief's voluntary medical male circumcision program through 2020 | E-poster | Scale up of medical male circumcision |
| EPC232 | Real-world impact of male circumcision on HIV seroprevalence in sub-Saharan Africa: a household fixed-effects analysis among 279,351 men from 29 countries | E-poster | Scale up of medical male circumcision |